News

Accentus Medical Appoints New Business Development Manager

01 September 2012

Oxford, 1 September 2012 … Accentus Medical, a global leader in silver-based anti-microbial implant surfaces, is pleased to announce the appointment of James Armstrong as Business Development Manager. James has over 10 years’ experience within the advanced coating technology industry and holds broad production and process knowledge. He has a track record of working within the high-growth SME sector, successfully achieving market traction and adoption of proprietary coating and other medical device technologies within multinational corporations, in the healthcare and other industry sectors.

James will have particular focus on identifying customers and licensing partners for Agluna®, our innovative surface technology that harnesses the anti-microbial properties of silver ions in preventing device related infection. He also has responsibility for leading organic growth of the company’s Acusure® range of plasma spray coatings, which have been applied to some 200,000 orthopaedic devices over the last decade. Acusure® is supported by solid regulatory and validation data, with a master file lodged with the FDA for the benefit of Accentus Medical’s customers. The Acusure® range is entering an exciting expansion phase with the development of viable coatings for non-metallic device substrates such as PEEK.

Philip Agg, Chief Executive Officer, said “I am delighted to welcome James to the management team. His knowledge and experience of helping to build businesses within high-growth international markets will be a tremendous asset to the company. He joins us at an exciting time in the commercial development of Accentus Medical within the global medical device sector.”

James Armstrong, added "The high cost of treating implant related infections has become a multi-billion dollar global problem for the medical device industry. Accentus Medical offers partners faced with this challenge value added technologies that can help tackle the problem, thereby differentiating brands, and improving margins or market share. I am looking forward to spearheading Accentus drive to have our surface technologies adopted on a global scale across all the major implant sectors."

-ends-

For further information, please contact:
Lynne Trowbridge, Tim Watson
Accentus Medical
T: +44 (0)20 7866 7861
Email: AccentusMedical@collegehill.com

About Accentus Medical
Accentus Medical is a global leader in delivery of innovative, silver-based anti-microbial surface treatments and biocompatible coatings on implantable medical devices. The company combines a long history of expertise in surface technologies, with dedicated research and development of new technologies for the medical device industry. Based at the historic Harwell Oxford campus, Accentus Medical has provided expertise in surface technologies to the orthopaedic device industry since the 1970s, serving major orthopaedic and medical device manufacturers worldwide.

The company has two principal technology platforms: Agluna® silver anti-microbial surface treatment for prevention and control of post-operative infection, and Acusure® plasma spray coating for improving biocompatibility and durability of implants. These technologies are supplied to customers at Accentus Medical’s ISO13485:2003 and ISO9001:2008 accredited facility. Accentus Medical is also very well known for the medical device testing programmes offered by its in-house test laboratories. Manufacturers have been utilising test results provided by the company for many years as part of device homologation files all over the world.

For further information, please visit: www.accentus-medical.com

Download PDF

Contact Us

T: +44 (0)1235 434 320
F: +44 (0)1235 434 329
E: enquiries@accentus-medical.com

Acusure